# Onegene Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/onegene-biotechnology

- Industry: Biotechnology
- Headquarters: South Korea
- Website: www.onegenebt.com
- Total disclosed funding: $48M
- Latest round: Series B (May 11, 2022)
- Investors on record: 20

## About

Based in South Korea, and founded in 2016, Onegene Biotechnology provides therapeutics that help in the treatment of chronic diseases. As of 2023, the company is headed by its CEO Dr. Sungjin Park. In May 2022, investors BNH Investments, Devsisters Ventures, ESV Investments, Korea Investment & Securities, Medici Investments, Premier Partners, Quantum Ventures Korea, Shinhan Venture Investment, Solid's Investments, Stick Ventures, Time Folio Asset Management, and UTC Investments raised KRW 40.7 billion in series B funding.

The company offers multi-targeting tri-or tetra-specific protein-based drugs which are developed by using different therapeutic modalities and it is helpful in the treatment of non-alcoholic steatohepatitis (NASH), fibrotic diseases, and cancers. The firm protein-binding platform technology (UniStac) removes the heterodimerization engineering process and uses Enzyme-mediated protein-protein conjugation technology which helps in the treatment of complex and chronic diseases.

## Funding rounds

- Series B, May 11, 2022, $32M — Korea Investment & Securities, Shinhan Venture Investment, Premier Partners, Time Folio Asset Management, Devsisters Ventures, Quantum Ventures Korea, BNH Investments, UTC Investments, Medici Investments, Stick Ventures, Solid's Investments, ESV Investments
- Series A, Feb 19, 2021, $16M — UTC Investment, Premier Partners, SJ Investment Partners, BNH Investment, Korea Omega Investment Corp., KB Securities, Quantum Ventures Korea, Stonebridge Ventures
- Seed, Sep 1, 2019 — Bluepoint Partners, Korea Tech Incubator for Startup

## Investors

- Bluepoint Partners (https://capitalatlas.ai/funds/bluepoint-partners) — Seed
- Korea Tech Incubator for Startup — Seed
- UTC Investment (https://capitalatlas.ai/funds/utc-investment) — Series A
- Premier Partners (https://capitalatlas.ai/funds/premier-partners) — Series A, Series B
- SJ Investment Partners (https://capitalatlas.ai/funds/sj-investment-partners) — Series A
- BNH Investment (https://capitalatlas.ai/funds/bnh-investment) — Series A
- Korea Omega Investment Corp. (https://capitalatlas.ai/funds/korea-omega-investment-corp) — Series A
- KB Securities (https://capitalatlas.ai/funds/kb-securities) — Series A
- Quantum Ventures Korea (https://capitalatlas.ai/funds/quantum-ventures-korea) — Series A, Series B
- Stonebridge Ventures — Series A
- Korea Investment & Securities (https://capitalatlas.ai/funds/korea-investment-securities) — Series B
- Shinhan Venture Investment (https://capitalatlas.ai/funds/shinhan-venture-investment) — Series B
- Time Folio Asset Management — Series B
- Devsisters Ventures (https://capitalatlas.ai/funds/devsisters-ventures) — Series B
- BNH Investments — Series B
- UTC Investments — Series B
- Medici Investments — Series B
- Stick Ventures — Series B
- Solid's Investments — Series B
- ESV Investments — Series B